Baird Medical Financials
| BDMDW Stock | 0.10 0.04 58.73% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 10.9 M | 11.4 M |
|
|
Investors should never underestimate Baird Medical's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Baird Medical's cash flow, debt, and profitability to make informed and accurate decisions about investing in Baird Medical Investment.
Net Income |
|
Baird | Select Account or Indicator |
Understanding current and past Baird Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Baird Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Baird Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Baird Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Baird Medical Investment. Check Baird Medical's Beneish M Score to see the likelihood of Baird Medical's management manipulating its earnings.
Baird Medical Stock Summary
Baird Medical competes with Regeneron Pharmaceuticals, Centessa Pharmaceuticals, Aspen Technology, Marti Technologies, and Lipocine. Baird Medical is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Healthcare, Medical Devices |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 30069X110 G0705H111 |
| Location | Hong Kong |
| Business Address | Room 202, Guangzhou, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.bairdmed.com |
| Phone | 86 20 8218 5926 |
Baird Medical Key Financial Ratios
| Revenue | 33.05 M | ||||
| Gross Profit | 29.22 M |
Baird Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Baird Medical's current stock value. Our valuation model uses many indicators to compare Baird Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Baird Medical competition to find correlations between indicators driving Baird Medical's intrinsic value. More Info.Baird Medical Investment is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers reporting about 1.02 of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all technique that is used if you cannot value Baird Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Baird Medical Investment Systematic Risk
Baird Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Baird Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Baird Medical Investment correlated with the market. If Beta is less than 0 Baird Medical generally moves in the opposite direction as compared to the market. If Baird Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Baird Medical Investment is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Baird Medical is generally in the same direction as the market. If Beta > 1 Baird Medical moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Baird Medical is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Baird has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Baird Medical's financials are consistent with your investment objective using the following steps:- Review Baird Medical's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Baird Medical's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Baird Medical's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Baird Medical's stock is overvalued or undervalued.
Baird Medical Thematic Clasifications
Baird Medical Investment is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Baird Medical March 16, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Baird Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Baird Medical Investment. We use our internally-developed statistical techniques to arrive at the intrinsic value of Baird Medical Investment based on widely used predictive technical indicators. In general, we focus on analyzing Baird Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Baird Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 19.46 | |||
| Information Ratio | 0.1353 | |||
| Maximum Drawdown | 500.9 | |||
| Value At Risk | (32.49) | |||
| Potential Upside | 56.6 |
Additional Tools for Baird Stock Analysis
When running Baird Medical's price analysis, check to measure Baird Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baird Medical is operating at the current time. Most of Baird Medical's value examination focuses on studying past and present price action to predict the probability of Baird Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baird Medical's price. Additionally, you may evaluate how the addition of Baird Medical to your portfolios can decrease your overall portfolio volatility.